BIOTRICITY INC. CONVERTIBLE PREFERRED NOTEBiotricity Inc. • February 14th, 2023 • Surgical & medical instruments & apparatus • New York
Company FiledFebruary 14th, 2023 Industry JurisdictionThis Note is a convertible preferred note referred to in that certain Subscription Agreement dated as of the date hereof (the “Subscription Agreement”), or series of like subscription agreements, among the Company and the Subscriber(s), pursuant to which the Company is seeking to raise an aggregate of up to $2,000,000 (the “Offering”).
BIONIK LABORATORIES CORP. CONVERTIBLE PROMISSORY NOTEBionik Laboratories Corp. • June 29th, 2017 • Orthopedic, prosthetic & surgical appliances & supplies • New York
Company FiledJune 29th, 2017 Industry JurisdictionThis Note is a convertible promissory note referred to in that certain Subscription Agreement dated as of the date hereof (the “Subscription Agreement”), or series of like subscription agreements, among the Company and the subscriber(s) named therein, pursuant to which the Company is seeking to raise an aggregate of up to $2,000,000.
BIONIK LABORATORIES CORP. CONVERTIBLE PROMISSORY NOTEBionik Laboratories Corp. • June 29th, 2017 • Orthopedic, prosthetic & surgical appliances & supplies • New York
Company FiledJune 29th, 2017 Industry JurisdictionThis Note is a convertible promissory note referred to in that certain Subscription Agreement dated as of the date hereof (the “Subscription Agreement”), or series of like subscription agreements, among the Company and the subscriber(s) named therein, pursuant to which the Company is seeking to raise an aggregate of up to $2,000,000.
BIOTRICITY INC. CONVERTIBLE PROMISSORY NOTEBiotricity Inc. • April 13th, 2016 • Surgical & medical instruments & apparatus • New York
Company FiledApril 13th, 2016 Industry JurisdictionThis Note is a convertible promissory note referred to in that certain Subscription Agreement dated as of the date hereof (the “Subscription Agreement”), or series of like subscription agreements, among the Company and the subscriber(s) named therein, pursuant to which the Company is seeking to raise an aggregate of up to $1,000,000.